• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多组学技术的高尿酸血症肾病发病机制研究进展:综述

Research progress on the mechanism of hyperuricemic nephropathy based on multi-omics technique: A review.

作者信息

Li Kaiqing, Xia Xue, Fu Tong, Ma Yanchun, Wang Yingwei, Fan Mingming, Wang Songyan, Xing Guoli, Tong Ying

机构信息

Heilongjiang University of Chinese Medicine, Harbin, China.

Brandeis University, Waltham, China.

出版信息

Medicine (Baltimore). 2024 Dec 20;103(51):e40975. doi: 10.1097/MD.0000000000040975.

DOI:10.1097/MD.0000000000040975
PMID:39705438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11666175/
Abstract

Hyperuricemic nephropathy is a metabolic disease in which renal uric acid deposition and excretion are impaired due to elevated levels of uric acid in the blood, leading to impaired renal tubule function and chronic renal disease. Hyperuricemic nephropathy is one of the important complications of hyperuricemia, which seriously affects the quality of life and prognosis of patients. The pathogenesis of hyperuricemic nephropathy involves a variety of factors, including: amino acid metabolism disorder, energy metabolism abnormality, increased nucleotide metabolism, lipid metabolism disorder and bile acid metabolism imbalance, REDOX process disorder, cell cycle and apoptosis imbalance, signal transduction and inflammatory response enhancement, and intestinal flora imbalance. In recent years, omics techniques such as metabolomics, transcriptomics and intestinal microecology have been used to reveal the metabolic, gene and microflora characteristics of hyperuricemic nephropathy from different levels, as well as their interactions and regulatory mechanisms. This paper reviews these studies, analyzes the existing problems and challenges, and puts forward future research directions and suggestions, aiming at providing new theoretical basis and practical guidance for the prevention and treatment of hyperuricemic nephropathy.

摘要

高尿酸血症肾病是一种代谢性疾病,由于血液中尿酸水平升高,导致肾脏尿酸沉积和排泄受损,进而引起肾小管功能障碍和慢性肾病。高尿酸血症肾病是高尿酸血症的重要并发症之一,严重影响患者的生活质量和预后。高尿酸血症肾病的发病机制涉及多种因素,包括:氨基酸代谢紊乱、能量代谢异常、核苷酸代谢增加、脂质代谢紊乱和胆汁酸代谢失衡、氧化还原过程紊乱、细胞周期和细胞凋亡失衡、信号转导和炎症反应增强以及肠道菌群失衡。近年来,代谢组学、转录组学和肠道微生态学等组学技术已被用于从不同层面揭示高尿酸血症肾病的代谢、基因和微生物群落特征,以及它们之间的相互作用和调控机制。本文对这些研究进行综述,分析存在的问题和挑战,并提出未来的研究方向和建议,旨在为高尿酸血症肾病的防治提供新的理论依据和实践指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/11666175/332b395b62a3/medi-103-e40975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/11666175/332b395b62a3/medi-103-e40975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/11666175/332b395b62a3/medi-103-e40975-g001.jpg

相似文献

1
Research progress on the mechanism of hyperuricemic nephropathy based on multi-omics technique: A review.基于多组学技术的高尿酸血症肾病发病机制研究进展:综述
Medicine (Baltimore). 2024 Dec 20;103(51):e40975. doi: 10.1097/MD.0000000000040975.
2
Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats.芪术泄浊方降低高尿酸血症肾病大鼠的血清尿酸水平并改善肾纤维化。
Biomed Pharmacother. 2017 Jul;91:358-365. doi: 10.1016/j.biopha.2017.04.031. Epub 2017 May 2.
3
Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.药理学靶向作用于细胞外信号调节激酶1/2可减轻大鼠高尿酸血症肾病的发生和进展。
Oncotarget. 2017 May 16;8(20):33807-33826. doi: 10.18632/oncotarget.16995.
4
Renal herb formula protects against hyperuricemic nephropathy by inhibiting apoptosis and inflammation.肾草方通过抑制细胞凋亡和炎症反应防治高尿酸血症肾病。
Phytomedicine. 2023 Jul 25;116:154812. doi: 10.1016/j.phymed.2023.154812. Epub 2023 Apr 8.
5
Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.天然类黄酮非瑟酮通过抑制 IL-6/JAK2/STAT3 和 TGF-β/SMAD3 信号通路减轻高尿酸血症肾病。
Phytomedicine. 2021 Jul;87:153552. doi: 10.1016/j.phymed.2021.153552. Epub 2021 Mar 22.
6
AMP-activated protein kinase α2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model.AMP 激活的蛋白激酶 α2 通过肾脏尿酸沉积导致急性和慢性高尿酸血症肾病的发生。
Eur J Med Res. 2022 Sep 10;27(1):176. doi: 10.1186/s40001-022-00800-1.
7
Linarin attenuates hyperuricemic nephropathy by modulating Nrf2/Keap1 and TLR4/NF-κB signaling pathways: Linarin attenuates hyperuricemic nephropathy.木犀草素通过调节Nrf2/Keap1和TLR4/NF-κB信号通路减轻高尿酸血症肾病:木犀草素减轻高尿酸血症肾病。
Phytomedicine. 2025 Apr;139:156440. doi: 10.1016/j.phymed.2025.156440. Epub 2025 Jan 29.
8
Control of renal uric acid excretion and gout.肾脏尿酸排泄与痛风的控制
Curr Opin Rheumatol. 2008 Mar;20(2):192-7. doi: 10.1097/BOR.0b013e3282f33f87.
9
Study on the Mechanism of Galangin on Hyperuricemic Nephropathy Based on Metabolomics and Network Pharmacology.基于代谢组学和网络药理学的高良姜素治疗高尿酸血症肾病的机制研究
Mol Nutr Food Res. 2025 May;69(9):e70029. doi: 10.1002/mnfr.70029. Epub 2025 Mar 27.
10
Ligusticum cycloprolactam ameliorates hyperuricemic nephropathy through inhibition of TLR4/NF-κB signaling.环丙内酯川芎通过抑制TLR4/NF-κB信号通路改善高尿酸血症肾病。
J Nutr Biochem. 2025 May;139:109864. doi: 10.1016/j.jnutbio.2025.109864. Epub 2025 Feb 13.

引用本文的文献

1
Progress in animal models for studying hyperuricemia.高尿酸血症研究动物模型的进展
Front Pharmacol. 2025 Aug 22;16:1636205. doi: 10.3389/fphar.2025.1636205. eCollection 2025.
2
Impacts of amino acid supplementation on renal function and nutritional parameters in patients with renal insufficiency: bibliometric analysis and meta-analysis.氨基酸补充对肾功能不全患者肾功能和营养参数的影响:文献计量分析与荟萃分析
Front Nutr. 2025 Jun 13;12:1594507. doi: 10.3389/fnut.2025.1594507. eCollection 2025.

本文引用的文献

1
Relationship between serum uric acid levels and osteoporosis.血清尿酸水平与骨质疏松症之间的关系。
Endocr Connect. 2023 Oct 13;12(11). doi: 10.1530/EC-23-0040. Print 2023 Nov 1.
2
Cadmium exposure dysregulates purine metabolism and homeostasis across the gut-liver axis in a mouse model.镉暴露通过小鼠模型中的肠-肝轴扰乱嘌呤代谢和内稳态。
Ecotoxicol Environ Saf. 2023 Nov 1;266:115587. doi: 10.1016/j.ecoenv.2023.115587. Epub 2023 Oct 13.
3
Effect of in vitro simulated digestion and fecal fermentation on Boletus auripes polysaccharide characteristics and intestinal flora.
体外模拟消化和粪便发酵对红菇多糖特性和肠道菌群的影响。
Int J Biol Macromol. 2023 Sep 30;249:126461. doi: 10.1016/j.ijbiomac.2023.126461. Epub 2023 Aug 22.
4
Possible correlated signaling pathways with chronic urate nephropathy: A review.可能与慢性尿酸盐肾病相关的信号通路:综述。
Medicine (Baltimore). 2023 Aug 11;102(32):e34540. doi: 10.1097/MD.0000000000034540.
5
Eurycoma longifolia alkaloid components ameliorate hyperuricemic nephropathy via regulating serum uric acid level and relieving inflammatory reaction.长叶勾儿茶生物碱成分通过调节血尿酸水平和缓解炎症反应改善高尿酸血症肾病。
J Nat Med. 2023 Sep;77(4):867-879. doi: 10.1007/s11418-023-01729-3. Epub 2023 Jul 12.
6
Structural analysis and attenuates hyperuricemic nephropathy of dextran from the Imperata cylindrica Beauv. var. major (Nees) C. E. Hubb.结构分析及减轻黄茅(Imperata cylindrica Beauv. var. major (Nees) C. E. Hubb.)葡聚糖的高尿酸血症肾病
Carbohydr Polym. 2023 Oct 1;317:121064. doi: 10.1016/j.carbpol.2023.121064. Epub 2023 May 29.
7
The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice.肠道微生物群失调-癌症轴:为临床实践提供新见解和启示
Front Pharmacol. 2023 Jun 9;14:1208044. doi: 10.3389/fphar.2023.1208044. eCollection 2023.
8
Study on the mechanism of Orthosiphon aristatus (Blume) Miq. in the treatment of hyperuricemia by microbiome combined with metabonomics.基于微生物组学和代谢组学探讨筋骨草治疗高尿酸血症的作用机制。
J Ethnopharmacol. 2023 Dec 5;317:116805. doi: 10.1016/j.jep.2023.116805. Epub 2023 Jun 22.
9
Urate-lowering drugs for chronic kidney disease with asymptomatic hyperuricemia and hypertension: a randomized trial.降尿酸药物治疗无症状高尿酸血症合并高血压的慢性肾脏病:一项随机试验。
J Hypertens. 2023 Sep 1;41(9):1420-1428. doi: 10.1097/HJH.0000000000003484. Epub 2023 Jun 8.
10
Chloroquine inhibits NLRP3 inflammasomes activation and alleviates renal fibrosis in mouse model of hyperuricemic nephropathy with aggravation by a high-fat-diet.氯喹抑制 NLRP3 炎性小体激活,并减轻高脂饮食加重的高尿酸血症肾病小鼠模型的肾纤维化。
Int Immunopharmacol. 2023 Jul;120:110353. doi: 10.1016/j.intimp.2023.110353. Epub 2023 Jun 3.